Amgen’s shares down after obesity drug fails to meet expectations

MarTide, the new weight loss drug from Amgen, works. Not just well enough for Wall Street. Shares of the Thousand Oaks-based biotech giant fell 10% on Nov. 26 after it announced that MarTide’s latest trial produced a body weight reduction of up to 20%. The results disappointed Wall Street, which had expected results of up Read More →

Good works: Central Coast Moving & Storage donates hundreds of turkeys

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
SoCal Edison sued in connection with Mountain Fire
As the investigation into the Mountain Fire’s origins continues, a class action lawsuit was filed Nov. 8 alleging that the Ventura County blaze was started by Southern California Edison’s equipment. The utility giant denies the allegations. The Ventura County Superior Court suit, alleging negligence and inverse condemnation, was filed by Pamela and Kenneth McWaid and seeks general Read More →
Olaplex’s struggles continue as earnings miss estimates

Montecito-based Olaplex missed analyst expectations in both revenue and net income when it announced its earnings for the third quarter of 2024. Announced Nov. 7, Olaplex noted that sales decreased 3.6% to $119.1 million in the third quarter of 2024.As a result, net income decreased 27.3% to $14.7 million and adjusted net income decreased 13.8% Read More →
Breaking: FEMA authorizes federal funds for use for Mountain Fire
In an effort to contain the Mountain Fire, which has scorched more than 10,000 acres across Ventura County and burned down more than two dozen homes, the Federal Emergency Management Agency announced the use of federal funds to assist California firefighters. The fire started on the morning of Nov. 6 near the 7900 block of Read More →

Amgen, investors focused on obesity drug candidate

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.